Fludarabine News
Schering AG Raises Outlook After Strong First Half Year
Berlin, Germany, The Schering AG Group (FSE: SCH, NYSE: SHR), Germany, expanded its business in the first six months of 2006 significantly and continued to increase its profitability. Net sales increased by 11% to EUR 2,824...
View Current Treatment Options for Chronic Lymphocytic Leukemia (CLL)
Dublin, Ireland -- Research and Markets has announced the addition of "Chronic Lymphocytic Leukemia: Monoclonal Antibodies Will Drive Steady Growth" to their offering.
Fludarabine effective in non-Hodgkin's lymphoma
New York - For patients with newly diagnosed low-grade non-Hodgkin's lymphoma (NHL), treatment with fludarabine is likely to be more effective than combination treatment with cyclophosphamide, vincristine and prednisone (CVP),...
Cyclophosphamide aids fludarabine against leukemia
New York - Adding cyclophosphamide to fludarabine results in greater response rates and longer treatment- and progression-free survival in younger patients with chronic lymphocytic leukemia (CLL), German researchers report in the...
Addition of Cyclophosphamide to Fludarabine Improves Progression
According to a recent article published in the journal Blood, the addition of cyclophosphamide (CytoxanŽ) to fludarabine (FludaraŽ) improves anticancer responses, progression-free survival, and time to subsequent treatment among...
Displaying results 6 to 10 out of 11